Keywords: مهار کننده های P2Y12; Dual-antiplatelet therapy (DAPT); coronary artery disease; guidelines; P2Y12 inhibitors; coronarystents;
مقالات ISI مهار کننده های P2Y12 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهار کننده های P2Y12; ACS; DAPT; P2Y12 inhibitors; Population-based study;
Keywords: مهار کننده های P2Y12; CHARISMA; Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events; ITALIC; Is There A LIfe for DES after discontinuation of Clopidogrel; PRODIGY; PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal
Keywords: مهار کننده های P2Y12; P2Y12 inhibitors; Network meta-analysis; Cangrelor;
Keywords: مهار کننده های P2Y12; ADP; Adenosine diphosphate; CABG; Coronary artery bypass graft; CTO; Chest tube output; CVE; Cardiovascular event; LTA; Light transmittance aggregometry; PFA-100; Platelet function analyser- 100; MEA; Multiple electrode aggregometry; PR; Platelet reactivi
Keywords: مهار کننده های P2Y12; antiplatelet therapy; aspirin; coronary stent; drug-eluting stent; P2Y12 inhibitors; ACS; acute coronary syndrome(s); BMS; bare-metal stent(s); CAD; coronary artery disease; DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); L-DAPT; long duratio
Effects of clopidogrel with or without aspirin on the generation of extracellular vesicles in the microcirculation and in venous blood: A randomized placebo controlled trial
Keywords: مهار کننده های P2Y12; Coronary heart disease; Dual-antiplatelet therapy; Extracellular vesicles; P2Y12 inhibitors;
Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers
Keywords: مهار کننده های P2Y12; adenosine; endothelial function; P2Y12 inhibitors; prasugrel; ticagrelor; ACS; acute coronary syndrome; ANOVA; analysis of variance; ENT1; equilibrative nucleoside transporter 1; FMD; flow-mediated dilation; LD; loading dose; MD; maintenance dose; RHI; re
The Timing of P2Y12 Inhibitor Initiation in the Treatment of ACS? Does the Evidence Exist in This Era?
Keywords: مهار کننده های P2Y12; ACS; Acute coronary syndrome; PCI; Percutaneous coronary intervention; CABG; Coronary artery bypass grafting; STEMI; ST-segment elevation myocardial infarction; NSTEMI; Non-ST-segment elevation myocardial infarction; MI; Myocardial infarction; CV; Cardiov
Contemporary Management of ST-Elevation Myocardial Infarction
Keywords: مهار کننده های P2Y12; ST-Elevation Myocardial Infarction; P2Y12 inhibitors; Thrombus aspiration; Non-culprit artery;
High platelet reactivity on aspirin in patients with acute ST elevation myocardial infarction
Keywords: مهار کننده های P2Y12; Aspirin; Myocardial infarction; Platelet reactivity; P2Y12 inhibitors
Prasugrel versus clopidogrel in acute coronary syndromes treated with PCI: Effects on clinical outcome according to culprit artery location
Keywords: مهار کننده های P2Y12; Acute coronary syndromes; P2Y12 inhibitors; Prasugrel;
Dyspnea related to reversibly-binding P2Y12 inhibitors: A review of the pathophysiology, clinical presentation and diagnostics
Keywords: مهار کننده های P2Y12; Pulmonary function; Pathophysiology; Discontinuation of medication; Oral anti-platelet agents; P2Y12 inhibitors; c-Fibers;
Pharmacokinetics and pharmacodynamics of oral P2Y12 inhibitors during the acute phase of a myocardial infarction: A systematic review
Keywords: مهار کننده های P2Y12; P2Y12 inhibitors; Primary percutaneous coronary intervention; ST elevation myocardial infarction; Inhibition of platelet activity (IPA); Platelet function assays; STEMI; Aspirin; Clopidogrel; Ticagrelor; Prasugrel;
Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention : A Network Meta-Analysis
Keywords: مهار کننده های P2Y12; angioplasty; clopidogrel; P2Y12 inhibitors; percutaneous coronary intervention; prasugrel; ST-segment elevation myocardial infarction; thienopyridines; ticagrelorACS, acute coronary syndrome(s); DES, drug-eluting stent(s); GPI, glycoprotein IIb/IIIa inhib
Optimal Antiplatelet Therapy in ST-Segment Elevation Myocardial Infarction
Keywords: مهار کننده های P2Y12; Antiplatelet agents; ST-segment elevation myocardial infarction; STEMI; P2Y12 inhibitors; GP IIb/IIIa inhibitors;
Efficacy and safety of P2Y12 inhibitors according to diabetes, age, gender, body mass index and body weight: Systematic review and meta-analyses of randomized clinical trials
Keywords: مهار کننده های P2Y12; Clopidogrel; Diabetes; Antiplatelet resistance; P2Y12 inhibitors; Thienopyridines; Meta-analysis; ASA; acetylsalicylic acid; BMI; body mass index; RCTs; randomized clinical trials; RR; relative risk; rRR; ratio of relative risk; T2DM; type 2 diabetes mell
Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention: Results of a Nonrandomized Observational Study
Keywords: مهار کننده های P2Y12; antiplatelet therapy; clopidogrel; P2Y12 inhibitors; prasugrel; ST-segment elevation myocardial infarction; ACS; acute coronary syndrome; BARC; Bleeding Academic Research Consortium; CI; confidence interval; HR; hazard ratio; IPTW; inverse probability of
Diferencias en los mecanismos de acción de los nuevos antiagregantes: ¿cómo actúan?
Keywords: مهار کننده های P2Y12; Trombosis; Inhibidores de P2Y12; Efectos pleiotrópicos; Thrombosis; P2Y12 inhibitors; Pleiotropic effects;
Relationship between changes in platelet reactivity and ischemic events following percutaneous coronary intervention: A meta-regression analysis of 30 randomized trials
Keywords: مهار کننده های P2Y12; Antiplatelet therapy; Platelet reactivity; Percutaneous coronary intervention; P2Y12 inhibitors; Meta-regression; ACS; acute coronary syndrome; HPR; high on-treatment platelet reactivity; MACE; major adverse cardiac events; PCI; percutaneous coronary inte
Impact of new oral or intravenous P2Y12 inhibitors and clopidogrel on major ischemic and bleeding events in patients with coronary artery disease: A meta-analysis of randomized trials
Keywords: مهار کننده های P2Y12; Antiplatelet therapy; P2Y12 inhibitors; Coronary artery disease; Meta-analysis;
Clopidogrel “resistance”: Pre- vs post-receptor determinants
Keywords: مهار کننده های P2Y12; Clopidogrel; P2Y12 inhibitors; Platelets; Anti-platelet agents; Thrombosis
Pharmacogenomics in Interventional Pharmacology
Keywords: مهار کننده های P2Y12; Pharmacogenomics; Interventional pharmacology; Clopidogrel; P2Y12 inhibitors; Cardiovascular medicine;